IE49409B1 - Azetidinone derivatives - Google Patents
Azetidinone derivativesInfo
- Publication number
- IE49409B1 IE49409B1 IE2340/84A IE234084A IE49409B1 IE 49409 B1 IE49409 B1 IE 49409B1 IE 2340/84 A IE2340/84 A IE 2340/84A IE 234084 A IE234084 A IE 234084A IE 49409 B1 IE49409 B1 IE 49409B1
- Authority
- IE
- Ireland
- Prior art keywords
- group
- general formula
- formula
- azetidinone derivative
- resultant
- Prior art date
Links
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 title claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 21
- -1 penicillanic acid S-oxide ester Chemical class 0.000 claims description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000741 silica gel Substances 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical group CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 claims description 2
- 239000012346 acetyl chloride Substances 0.000 claims description 2
- 238000005904 alkaline hydrolysis reaction Methods 0.000 claims description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- 125000000468 ketone group Chemical group 0.000 claims description 2
- 238000005949 ozonolysis reaction Methods 0.000 claims description 2
- 235000009518 sodium iodide Nutrition 0.000 claims description 2
- 238000006317 isomerization reaction Methods 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 34
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 16
- 239000000243 solution Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000001704 evaporation Methods 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 8
- 229910052938 sodium sulfate Inorganic materials 0.000 description 8
- 235000011152 sodium sulphate Nutrition 0.000 description 8
- 101150041968 CDC13 gene Proteins 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 6
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical group C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 5
- 125000006519 CCH3 Chemical group 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical group O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 235000019256 formaldehyde Nutrition 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- RCCPEORTSYDPMB-UHFFFAOYSA-N hydroxy benzenecarboximidothioate Chemical compound OSC(=N)C1=CC=CC=C1 RCCPEORTSYDPMB-UHFFFAOYSA-N 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- DJANLSNABDFZLA-RQJHMYQMSA-N methyl (2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Chemical compound S1C(C)(C)[C@H](C(=O)OC)N2C(=O)C[C@H]21 DJANLSNABDFZLA-RQJHMYQMSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- MHSGOABISYIYKP-UHFFFAOYSA-N (4-nitrophenyl)methyl carbonochloridate Chemical compound [O-][N+](=O)C1=CC=C(COC(Cl)=O)C=C1 MHSGOABISYIYKP-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- AOJDZKCUAATBGE-UHFFFAOYSA-N bromomethane Chemical compound Br[CH2] AOJDZKCUAATBGE-UHFFFAOYSA-N 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- RBKMMJSQKNKNEV-RITPCOANSA-N penicillanic acid Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2CC(=O)N21 RBKMMJSQKNKNEV-RITPCOANSA-N 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005055 short column chromatography Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
The invention relates to processes for the preparation 5 of azetidinone derivatives and to certain of the azetidinone derivatives.
More particularly the invention relates to azetidinone derivatives of the general formula 1 wherein R' represents a hydrogen atom or an alkyl, alkoxy, or hydroxyaikyl group, each of which has from 1 to 4 carbon atoms, the alcoholic function of the hydroxyaikyl group being free or protected by a p. nitrobenzyloxycarbonyl group; and X represents a group of the formula CHgZ or CH^Z1 wherein Z representsa hydroxy, amino or carbamoyloxy group, or a group of the formula OR^ or OCOR^ wherein R^ represents an alkyl group having from 1 to 4 carbon atoms and Z’ represents a mercapto or pyridinium group, or a 20 group of the formula SRg wherein R3 represents an alkyl group having from 1 to 4 carbon atoms or a 5-methyl-l,3, 4-thiadiazol-2-yl, l-methyl-lH-tetrazol-5-yl, 1,2,3,-triazol-5-yl or pyrazinyl group. The 3-substituent may have the a- or β-configuration. 3o-substitution is preferred. - 3 The invention provides a process for the preparation of compounds of the general formula I in which R' is as above defined and X represents a group of the formula CHgZ wherein Z is as above defined. The process is 5 illustrated by the following reaction scheme, in which R' is as above defined, R represents an alkyl group and Y represents a hydrogen atom, a lower alkyl, cyano or alkoxycarbonyl group or a group of the formula CHgZ in which Z is as above defined. 494 09 (13) 48409 - 5 The process comprises condensing, in an inert solvent at elevated temperature, a penicillanic acid S-oxide ester of the general formula (2) with an acetylenic compound of the general formula TCHjCaCY, isanerising the resultant caipound of the general formula (3), preferably in basic conditions, reducing the 4£-(substituted vinylsulphinyl) group of the resultant azetidinone derivative of the general formula (4) by the action of a reducing agent, submitting the resultant azetidinone derivative of the general formula (12) to ozonolysis in solution at reduced temperature whereby both carbon-carbon double bonds are converted to keto groups, and removing the 1-alkoxyoxalyl group from the resultant azetidinone derivative of the general formula (13) by mild alkaline hydrolysis or by the action of silica gel.
The preparation of compounds of the general formula I in which R' is as herein defined and X represents a group of the formula CHjZ' in which 2' is as herein defined is carried out according to the above process with the additional step of converting the substituent 2 into a substituent of the formula 2'. The additional step may be carried out at any stage in the above process after the condensation of the penicillanic acid S-oxide ester (2) with the acetylenic ccnpound ZCH^CaCY and is necessary because of the difficulty of condensing the penicillanic acid S-oxide ester (2) directly with an acetylenic compound HSCHg-OCY, R^SCHj-CsCY or PyCHj-CSSY in which Py represents a - 49*09 - 6 pyridinium ion. This process is also within the scope of the invention.
The reduction of the azetidinone derivative (4) may be carried out using phosphorus tribromide or sodium iodide in acetyl chloride as reducing agent.
'.'Tien R' represents a hydroxyalkyl group in the desired compound of the general formula I» the reaction sequence is preferably carried out with the alcoholic function protected.
The starting materials of the general formula (2) in which R' represents a hydrogen atom may be prepared from (5R)~ -6-aminopenicillanic acid following known procedures (see Cignarella et al.. Journal of Organic Chemistry, 27, 2668 and EVRARD et al., Nature, 201, 1124). .15 When R' represents a ci-c4 alkyl or hydroxyalkyl nroup, it can be introduced according to the procedure of Di Ninno et al., Journal of Organic Chemistry 42, 2960 (1977). When R' represents a C^-C^ alkoxy group, it may be introduced according to the procedures of Hauser et al., Helv. Chem.
Acta, 50, 1327 (1967) and Giddings et al.. Tetrahedron Letters, Il, 995, (1978). Alternatively compounds of general formula (2) in which R' represents a hydrogen atom can be converted to compounds of the general formula (2) in which R' represents a C^-C^ alkyl or hydroxyalkyl group - 7 by introducing the substituent into the 6-position using a strong base, as illustrated in the following Examples. Compounds of the general formula (2) in which R' represents a C^-C^ alkyl or hydroxyalkyl group can also be prepared starting from a suitable ester of penicillanic acid S-oxide, as illustrated in the following Examples. The substitution at the 3-position is stereospecifically directed to the 3O.-derivatives.
The compounds of the general formula I as above defined are useful as intermediates in the preparation of certain penem-carboxylic acids and esters which have a wide spectrum of antibacterial activity as well as a p-lactamase inhibiting activity (see specification of Application No. 338/80, from which this Application is divided). It should be pointed out that the stereochemistry at C^ of the compounds according to the invention, as well as that of all the intermediates of their preparation, is the same as in naturally occurring penicillins and cephalosporins.
Certain of the compounds of the general formula I as above defined themselves form part of the invention. They are those in which X represents a group of the formula CH^A in which A represents a carbamoyloxy or pyridinium group or a group of the formula OCORj - 8 or SR^ wherein Rj and are as above defined and R' represents a hydroxyalkyl group having from 1 to 4 carbon atoms, the alcoholic function of the hydroxyalkyl group being free or protected by a p-nitro5 benzyloxycarbonyl group. Preferably R' represents a 1-hydroxyethyl or 1-(p-nitrobenzyloxycarbonyloxy)-ethyl group. i 49408 - 9 The following Examples illustrate the invention.
EXAMPLE 1 4β-(l-acetoxymethy1-3-acetoxy-l-propeny1sulphlny1)-1- (l-methoxycarbony1-2-methyl-ally1) -'azetidin-'2-one (3): R=CH3; R'=H, Y=CH2O.CO.CH3, Z=0C0CH3 A solution of 2.0 g of methyl penicillinate S-oxide and 2.8 g of butyndiol diacetate in 40 ml of toluene was refluxed for 24 hours. 1.4 g of the title compound was obtained after purification by column chromatography on silica gel eluting with 96:4 by volume dichloromethane:ethyl acetate.
PMR (CDC13) · 2.03 δ (s, CHg-C-), 2.15 and 2.20 g (two s, 2 CH3CO), 2.88 δ (dd, Jgex = 14Hz, Jvic cis = 4 Hz, C-3-Ηα) t 3.38 δ (dd, J gem = 14Hz, Jvic trans = 2Hz, C-3-H5) 9 3.83 δ (S, ch30), 4.88 δ (<3, Jvic = 6Hz, CH--C-) * 1 (H) 4.92 δ (broad s, CH2~C= b ι « -N C 4.93-5.33 6 (m, =¾ and ) COO .32 6 (dd, Jvic = 4 and 2Hz, C-4-H) , 6.47 δ (t, Jvic = 6Hz, =C-C(H2)) vt - 10 EXAMPLE 2 g-(1-acetoxymethy1-3-acetoxy-l-propenylsulphinyl)-1- (l-methoxycarbonyl-2-methyl-l-propenyl) -azetidin-2-one (4): R=CH3, R’=H, Y=CH2O.CO.CH3 , Z=QCOCH3 1.7 g of the compound prepared in Example 1 were dissolved in 80 ml of dichloromethane. 0.5 ml of triethylamine were added and the solution was left for a few hours at room temperature. After evaporating off the solvent, the title compound was obtained in pure form in quantitative yield.
PMR (CDC13) : 2.14 (9H) and 2.32 (3H) δ (two s, 2 CH3C0 and 2 CH3-C=), 2.92 δ (dd, Jgem=15Hz, Jvic cis =5Hz, C-3-HQ), 3.38 δ (dd, Joem=15Hz, Jvic trans = 2.5Hz, C-3-Ηβ), 3.82 δ (s, CH30) 4.88 δ (d, Jvic=6.5Hz, CH2-C=, 4.92 δ (s, (H) CH2-C=), 5.15 δ (dd, Jvic=5 and 2.5Hz, C-4-H), 6.50 δ (t, Jvic 6.5Hz, =C- (H-j)) H EXAMPLE 3 20-4 B-acetylglycolloylthio-l-acetoxymethoxyoxalyl-azetidin-2-one. (13): R= CH2O.CO.CH3, R'=H , X=0.C0.CH3 0.8 g of 48-(1-acetoxymethy1-3-acetoxy-l-propenylthio)-125 -(l-acetoxymethoxycarbonyl-2-methyl-l-propenyl)-azetidin-2-one were dissolved in 80 ml of dichloromethane and cooled to -78°C. A flow of ozone in oxygen was bubbled - 11 through the solution until a blue colour appeared. The solution, after shaking with an aqueous solution of sodium pyrosulphite, was dried over anhydrous sodium sulphate.
The solvent was removed by evaporation to give 0.45 g of the title compound.
PMR (CDC13) : 2.10 and 2.13 6 (two s, 2CH3CO), 3.20 δ (dd, Jgem= 17Hz, Jvic trans = 3.5Hz, C-3-Ηβ), 3.77 δ (dd, Jgem=17Hz, Jvic cis=5.5Hz, C-3-Ha) 4.73 δ (s, -CO-CH2-OCO-), 5.73 δ (dd, Jvic= 10 5.5 and 3.5Hz, C-4-H), 5.87 δ (s, COO-CHj-OCO) EXAMPLE 4 4E-acetylglycolloylth3o-azetidin-2-one (14): R'=H, Z=O.CO.CH3 0.6 g of 4S-acetylglycolloylthio-l-methoxyoxalyl-azetidin15 -2-one were dissolved in'100 ml of methanol and a few grams of silica gel were added under stirring. After one hour the silica gel was filtered off and the resulting solution gave, after evaporation of the solvent therefrom, 0.35 g of the title compound.
PMR (CDClg) : 2,20 δ (s, CHgCO), 3.03δ (cd, Jqem =16Hz, Jvic trans=2.5Hz, C-3-H6), 3.50 δ (dd, Jgem= 16Hz, Jvic cis=4.5Hz, C-3-Hs ) , 4.77 δ (s, -CO-CH2-OCO-), 5.32 « (dd, Jvic=4.5 and 2.5Hz, C-4-H), 6.40 { (broad s, ΚΞ). - 12 EXAMPLE 5 4g- (l-hydroxymethyl-vlnylsulphinyl)-1-(l-methoxycarbonyl-2-methyl-allyl)-azetidin-2-one. (3): R=CH3, R’=Y=H, ?.=OH 4 g of methyl penicillanate S-oxide were dissolved in 15 ml of toluene and refluxed with 15 ml of propargyl alcohol for 8 hours. After evaporating off the solvent in vacuo, the residue was purified by short column chromatography on silica gel, eluting with dichloromethane:ethyl acetate (1:1 by volume]. 2.8 g of the title compound were obtained.
PMR (CDC13)δ :1.96 (bs, 3 H, C-CH3); 2.91 and 3.35 (dd, 2H, J=2Hz, 5Hz, 15Hz, CO-CH2-CH-S); 3.78 (s, 3 H CCCCH3)j 4.36 (bs, 2 H, CH70H); 4.90-5.25 (m, 3 H, CH-C00CH3, C-C=CH2); 5.35 (m, 1 H, CE--CH-S)ί 5.88 (s, 2 H, CH2=C-S).
EXAMPLE 6 8-(1-hydroxymethyl-vlnylsulphinyl)-l-(l-methoxycarbonyl-2-methyl-l-propenyl)-azetidin-2-one (4): R=CH3, R'=Y=H, Z=OH 3.0 g of the compound prepared in Example 5 were dissolved in 100 ml of di chloromethane and left at room temperature for a few hours. After evaporating the solvent from the solution, the residue consisted of the title compound in pure form. Quantitative yield.
PMR (CDC13) δ :1.38 (s, 3 H, =C-CH3); 2.18 (s, 3 H, =C-CH3); 2.~-3.6 (m, J=2Hz, 16Hz, C0-CH7-CH-S); - 13 3.78 (s, 3 H, C00CH3); 4.35 (s, 2 H, CHjOH); .32 (m, 1 H, CH-S) ; 5.90 (bs, 2 H, =¾) · EXAMPLE 7 6-(l-bromomethyl-vinylthio)-1-(l-methoxycarbonyl-2-methyl -1-propenyl)-azetidln-2-one. (12): R=CH3, R'=Y=H, Z=Br 1.8 σ of the compound prepared in Example 5 were dissolved in 40 ml of dimethylformamide and cooled to -20°C. 0.7 ml of pyridine and 3.0 ml of phosphorus tribromide were added and the mixture was left for 15minutes under stirring. Ethyl acetate was added and the organic layer was shaken with a saturated solution of sodium bicarbonate;' washed with water and then dried over anhydrous sodium sulphate to give, after evaporating off the solvent, 1.6 g of the title compound.
CH PMR (CDC1,) δ :2.04 (s, 3 H, 7 3)· 2.24 (s, 3 H ); 3 CH 3.24 (dd, J=2.8, 5, 16Hz, 2 H, 3 C-CHj-CH) ; 3.75 (s, 3 H, 0¾) ; 4.02 (s, 2 H, CH2Br); 5.24 (bs, 1 H, =CH); 5.37 (dd, J=2.8Hz, 5Hz, 1 H, CHj-CH-S); 5.60 (bs, 1 H, =CH).
EXAMPLE 8 4β-/1- (1-me thy l-lH-tetrazol-5-yl-thiome thyl) -vinylthio7-l-(l-methoxycarbonyl-2-methyl-l-propenyl)-azetldln-2-one - 14 (12): R=CH3, R'=Y=H, 1.4 σ of the compound prepared in Example 7 were dissolved in 25 ifal of tetrahydrofuran and cooled to O°C. 0.8 g of l-methyl-5-wercapto-tetrazole sodium salt were added and the mixture was left under stirring for three hours at room temperature. After filtering off the insoluble matter, the mixture was diluted with ethyl acetate, washed with water, dried over anhydrous sodium sulphate and evaporated to dryness. The residue consisted of 2.0 g of the title compound in pure form.
PMR (CDC13) 6 :2.00 (s, 3 H, = C-CHj)ϊ 2.22 (s, 3 H, =C-CH3) 2.70-3.80 (m,.2 H, J=2Hz, 5Hz, 15Hz, CO-CH2~ -CH-S) ; 3.72 (s, 3 H, COOCH-j); 3.95 (s, 3 H, N-CH3); 4.10 (s, 2 H, CH-j-S) ; 5.18 (bs, 1 H, S-C=CH); 5.36 (m, 1 H, CHj-CH-S); 5.57 (bs, H, S-C=C-H).
EXAMPLE 9 (l-methyl-l-H-tetra2ol-5-yl-thio)-acetylthio7"l~ methoxyoxalyl-azetidin-2-one. 1.8 g of the compound prepared in Example 8 were dissolved .20 in 200 ml of dichloromethane and cooled to -78°C.
A flow of ozonized oxygen was bubbled through the solution until a blue colour appeared. A few drops of trimethylphosphite were added and the mixture was raised to room temperature. Removal of the solvent by evaporation gave 1.3 g of the title compound.
PMR (CDC13) δ 2.9-3.7 (>, 2 H, COCHgCH S); 3.85 (s, 3 H, COOCH3; 3.98 (s, 3 H, N-CH3>; 4.35 (s, H, CHgS); 5.75 (m, 1 H, CHjCH S).
EXAMPLE 10 46-((1-methyl-l-H-tetra2Ql-5-yl-thio)-acetylthio]-azetidin-2-one.
N·-N 1.2 g of the compound prepared in Example 9 were dissolved in a 1:1 by volume ethyl acetate:methanol mixture and a few grams of silica gel were added under vigorous stirring. After one hour the insoluble matter was filtered off and the solution was evaporated in vacuo. The title compound was crystallized from methanol:diethyl ether: 0.6 g were obtained.
EXAMPLE 11 .25 methyl 6-(1-hydroxyethyl)-3-penicillanate To a solution of 2.2 g of methyl penicillanate in 30 ml - 16 of anhydrous tetrahydrofuran, a slight excess of lithium diisopropylamide was added at -78°C under nitrogen. An excess of acetaldehyde was dropped in and the mixture was stirred for 5 minutes. The reaction was then quenched with a trace of acetic acid; the mixture was poured into water and extracted with dichloromethane. The organic layers were dried over anhydrous sodium sulphate and evaporated in vacuo to give 0.8 g of the title compound.
EXAMPLE 12 methyl 6-(1-p-nitrobenzyloxycarbonyloxyethyl)-3-penicillanate 1.2 g of methyl 6-(l-hydroxyethyl)-3-penieillanafee, prepared as described in Example 11, were dissolved in 40 ml of tetrahydrofuran cooled to -78eC and treated with one equivalent of butyl lithium. 1.2 equivalents f. of p-nitrobenzyloxycarbonyl chloride were added xo the mixture. After 30 minutes at -78°C, the reaction mixture was left at room temperature for 60 minutes, poured into water and extracted with dichloromethane. 1.4 g of the title compound were obtained after drying over anhydrous sodium sulphate and evaporating off the solvent.
EXAMPLE 13 γ. methyl-6-(l-p-nitrobenzyloxycarbonyloxyethyl-5— -penicillanate-S-oxide 409 - 17 0 1.8 g of methyl 6-[l-p-nitrobenzyloxycarbonyloxyethyl]-3-penicillanate, prepared as described in Example 12, were dissolved in 50 ml of dichloromethane and treated at 0°C with 1.5 equivalents of m-chloroperbenzoic acid. The organic phase was shaken with a saturated solution of sodium bicarbonate, extracted, dried over anhydrous sodium sulphate and evaporated: 1.4 g of the expected sulphoxide were obtained.
EXAMPLE 14 4B~(l-acetoxymethyl-3-acetoxy-l-propenylsulphinyl)-3-(1-p-nitrobenzyloxycarbonyloxyethyl)-l-(l-methoxycarbonyl-2-methyl-allyl)-azetidin-2-one (3): R=CH3, R'=CH3CH.0 A solution of 2.0 g of the compound prepared in Example 13 and 2.4 g of butyndiol diacetate in 50 ml of toluene was refluxed for 24 hours. The trapped compound was then purified by silica gel column chromatography eluting with 9:1 by volume dichloromethane:ethyl acetate. 1.1 g of the title compound were obtained.
EXAMPLE 15 48-(l-acetoxymethyl-3-acetoxy-l-propenylsulphinvl)-3-(1-p-nitrobenzyloxycarbonyloxyethyl)-1-(I-meth=xycarbonyl-2-methyl-l-propenyl)-azetidin-2-one - 18 (4): R=CH3, R'=CH3CH.O.C.OCH2 NOj, Y=CH2O.CO.CH3,Z=OCOCH3 1.3 g of the compound prepared in Example 14 were dissolved in 80 ml of dichloromethane. 0.3 ml of triethylamine were added and the mixture was left at room temperature for 2 hours. The title compound was obtained in pure form in quantitative yield by evaporating off the solvent.
EXAMPLE 16 48-(1-acetoxymethyl-3-acetoxy-l-propenylthio)-3-(1-p-nitrobenzyloxycarbonyloxyethyl)-l-metboxycarbonyl-2-methyl-l-propenyl)-azetidin-2-one. 11 Γ\ (12 ) : R=CH3, R' =CH3CH. 0. C. 0CH2 1.5 g of the compound prepared in Example 15 were dissolved in 10 ml of anhydrous dimethylformamide and cooled to -20°C. 0.8 ml of phosphorus tribromide were added, and the mixture was stirred for 10 minutes. It was then diluted with ethyl acetate and washed twice with a saturated solution of sodium bicarbonate. The organic layer was dried over anhydrous sodium sulphate and evaporation off of the solvent gave 1.1 g of the title compound.
EXAMPLE 17 46~acetylglycolloylthio-3-(l-p-nitrobenzyloxycarbonyloxyethyl)-l-methoxyoxalyl-azetidin-2-one. 43409 - 19 ' /"λ (13) : R=CH3, R'=CH3CH.O.C.OCH2/ o\ NO2, Z-O.CO.CHj 1.4 g of the compound prepared in Example 16 in 120 ml of dichloromethane were cooled to -78°C. Ozone in oxygen was bubbled through the solution until a blue colour appeared. The solution was shaken with an aqueous solution of sodium pyrosulphite and dried over anhydrous sodium sulphate. Evaporation off of the solvent gave 0.8 g of the title compound.
EXAMPLE 18 46-acetylglycolloylthio-3-(l-p-nitrobenzyloxycarbonyloxyethyl)-azetidin-2-one • 10 11 * * * 15 * * * * 20 (14) : R'=CH3CH.O.C.OCH2 NOj, Z=O.CO.CH3 0.800 g of the compound prepared in Example 17 were dissolved in 50 ml of methanol and a few grams of silica gel were added. The mixture was left at room temperature for 60 minutes, and then the insoluble material was filtered off. The filtrate, after the solvent had been removed by evaporation, gave 0.300 g of the title compound.
Claims (8)
1. A process for the preparation of an azetidinone derivative having the general fonnula I wherein R' is as herein defined and X represents a group of the formula CH 2 Z wherein Z is as herein defined, the process comprising condensing, in an inert solvent at elevated temperature, a penicillanic acid S-oxide ester of the general formula (2) as herein defined with an acetylenic compound of the general formula ZC^CsCY wherein Z is as herein defined, isomerizing the resultant compound of the general formula (3) as herein defined, reducing the 4(3-(substituted vinylsulphinyl) group of the resultant azetidinone derivative of the general formula (4) as herein defined by the action of a reducing agent, submitting the resultant azetidinone derivative of the general formula (12) as herein defined to ozonolysis in solution at reduced temperature whereby both carbon-carbon double bonds are converted to keto groups, and removing the 1-alkoxyoxalyl group from the resultant azetidinone derivative of the general formula (13) as herein defined by mild alkaline hydrolysis or by the action of silica gel. t
2. A process for the preparation of an azetidinone derivative having the general formula I wherein R' is as herein defined and X represents a group of the 4-9409 formula CHjZ' wherein Z' is as herein defined, the process being as defined in claim 1 with the additional step of converting the substituent 2 into a substituent Z' as herein defined, the additional step being carried out at any stage in the process after the condensation of the penicillanic acid S-oxide ester with the acetylenic compound.
3. A process according to claim 1 or claim 2 in which the isomerization is carried out in basic conditions.
4. A process according to any preceding claim in which the reducing agent is phosphorus tribromide or sodium iodide in acetyl chloride.
5. A process according to claim 1, the process being substantially as described herein with reference to Examples 14 to 18.
6. A process according to claim 2, the process being substantially as described herein with with reference to Examples 5 to 10.
7. An azetidinone derivative having the general formula I wherein R' represents a hydroxyaikyl group having from 1 to 4 carbon atoms, the alcoholic function of the hydroxyaikyl group being free or protected by a g-nitrobenzyloxycarbonyl group, and X represents a group of the formula CHjA wherein A is as herein defined.
8. 4f> -acetylglycolloylthio-3-(l-g-nitrobenzyloxycarbonyloxyethyl)-azetidin-2-one.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7906634 | 1979-02-24 | ||
GB7932591 | 1979-09-20 | ||
IE338/80A IE49407B1 (en) | 1979-02-24 | 1980-02-20 | Antibacterial agents and beta-lactamase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
IE842340L IE842340L (en) | 1980-08-24 |
IE49409B1 true IE49409B1 (en) | 1985-10-02 |
Family
ID=27260678
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2340/84A IE49409B1 (en) | 1979-02-24 | 1980-02-20 | Azetidinone derivatives |
IE234184A IE49410B1 (en) | 1979-02-24 | 1980-02-20 | Azetidinone derivatives |
IE2339/84A IE49408B1 (en) | 1979-02-24 | 1980-02-20 | Azetidinone derivatives |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE234184A IE49410B1 (en) | 1979-02-24 | 1980-02-20 | Azetidinone derivatives |
IE2339/84A IE49408B1 (en) | 1979-02-24 | 1980-02-20 | Azetidinone derivatives |
Country Status (1)
Country | Link |
---|---|
IE (3) | IE49409B1 (en) |
-
1980
- 1980-02-20 IE IE2340/84A patent/IE49409B1/en not_active IP Right Cessation
- 1980-02-20 IE IE234184A patent/IE49410B1/en not_active IP Right Cessation
- 1980-02-20 IE IE2339/84A patent/IE49408B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE49408B1 (en) | 1985-10-02 |
IE842339L (en) | 1980-08-24 |
IE49410B1 (en) | 1985-10-02 |
IE842340L (en) | 1980-08-24 |
IE842341L (en) | 1980-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Leanza et al. | An efficient synthesis of 2-substituted-thio-6-hydroxyethyl-penem-3-carboxylic acids via 2-thioxopenams | |
HU198011B (en) | Process for producing optically active acyl-azetidinones | |
IE49407B1 (en) | Antibacterial agents and beta-lactamase inhibitors | |
CA1234099A (en) | Process for the production of penems | |
DK166152B (en) | PROCEDURE FOR THE PREPARATION OF PENEM CONNECTIONS | |
FI86852C (en) | New compounds and processes for their preparation | |
US4024152A (en) | 4-Dithio-3-imido-azetidin-2-ones | |
FR2518098A1 (en) | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE PENEM DERIVATIVES | |
JPH03396B2 (en) | ||
IE49409B1 (en) | Azetidinone derivatives | |
EP0283253B1 (en) | Method for preparation of azetidinone-1-oxoacetate by oxidation of the corresponding 2-hydroxyacetate | |
RU2024528C1 (en) | Method of synthesis of stereospecific compound | |
GB2116167A (en) | Azetidinone derivatives | |
PL172378B1 (en) | Method of obtaining novel 4-substituted azetidinones | |
EP0365223A2 (en) | Process for the preparation of penems | |
GB2104893A (en) | Azetidinone derivatives | |
KR910003612B1 (en) | Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives | |
FI82698B (en) | FOERFARANDE FOER FRAMSTAELLNING AV PENEMFOERENINGAR. | |
US5075439A (en) | Processes for (3S,4R)-3-[1(R)-t-butyl-dimethylsilyloxy)-ethyl]-4-[1-oxo-3-thiolanylthio(thiocarbonyl)thio]azetidin-2-ones and intermediates therefor | |
JP3059475B2 (en) | Method for producing 2-azetidinone derivative | |
GB2114132A (en) | Azetidinone derivatives | |
US4554103A (en) | Preparation of 4-acyloxyazetidinones from acyl nitrates and penams | |
BE889151A (en) | PENEME-3-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHODS THEREOF AND THERAPEUTIC APPLICATION THEREOF | |
NL8002843A (en) | PENICILLINS. | |
JPH0222759B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed |